Meet The Team

Stanley Capital has formed an Automation and AI solutions business in partnership with leading AI providers such as Math Labs and Eigen Technologies in order to create proprietary products both for the running of Stanley Capital and for value creation in its investments as well as portfolio companies

A Stanley Capital investment is based on deep thematic research across our three core verticals. Our Research team seeks to develop deep insights into specific subsectors helping us to fully understand the underlying market and its players better and earlier than our competition. A Vice President, an Associate and an Analyst dedicated to research assist our deal thesis development as well as our early identification of potential targets. Our subsector research papers define, assess and segment each market and their respective competitive landscapes.

image description

Simon Cottle

Partner
Career Highlights:
  • Simon is a Founding Partner at Stanley Capital and a Board Member of Noden Pharma. Simon has originated and led the Noden Pharma and Essential deals since at Stanley
  • Simon’s lead investor experience was as a Managing Director and IC member at Ardian and Director at Hg Capital. At Ardian and HgCapital Simon led or co-led deals into Parts Alliance, GSF, DDS Software, Zenith, Leasedrive, Trigo and Envision Pharma. Simon was named as one of the top 40 under 40 private equity practitioners in the inaugural Financial News awards in 2013
  • Simon’s pre investing background was as an investment banker at Deutsche Bank and Citigroup, a technology and healthcare management consultant at Arthur D Little. Simon was a British Olympian in the Athens Olympic Games in 2004 (Rowing) and holds an MBA (INSEAD) and an MA (Oxford) where he was a Richard Blackwell Scholar and multiple College Prize winner in 1997 and 1998. Before university Simon held an IBM Scholarship in Computer Science where he helped program early voice recognition software
Background:
  • Managing Director and IC member – Ardian Buyout
  • Director – HgCapital
image description

Patrick Hargutt

Partner
Career Highlights:
  • Patrick is a Founding Partner at Stanley Capital and a Board Member of Noden Pharma. He co-led Stanley’s investment into Noden
  • Patrick is a private equity and special situations investor with a strong track record across both equity and debt transactions
  • Prior to Stanley Capital, Patrick was an investor at Centerbridge Partners and Monarch Alternative Capital. He started his career as an investment banker at JP Morgan
  • Patrick received a Masters in Mathematics at the Technical University Munich with summa cum laude. He is the author of the mathematical specialist book “A Fractional Heath-Jarrow-Morton Approach for Interest Rate Markets“, published while on a post-graduate research scholarship at Imperial College London
Background:
  • Vice President – Monarch Alternative Capital
  • Centerbridge Partners
  • JP Morgan
image description

James Brooks

Partner
Career Highlights:
  • James is a Founding Partner at Stanley Capital and co-led Stanley’s investment into Noden Pharma
  • James is a Special Advisor to Shell for energy transition execution strategies. Until September 2021 he was on the leadership team of Shell’s R&ES division, responsible for strategy and investment decision making for platforms across power, e-mobility, hydrogen, carbon offsets and venture investing
  • From 2016 – 2020, James co-led the rapid growth of Lightsource BP to become a global leader in the renewable energy sector. In that same period, James has founded, raised and worked as Managing Partner of one of the world’s largest emerging market-focused green private equity funds, Eversource Capital, and completed investments across utility scale and distributed energy, mobility, water and waste management sectors
  • Prior to joining Lightsource BP, James was co-head of EMEA Energy and UK & Ireland for Goldman Sachs’s Merchant Banking Division, its principal investment platform. Prior to GS, James worked at First Reserve and Advent International
  • James received his Masters and BA degree in Physics from Merton College, University of Oxford
Background:
  • Strategy Director – Lightsource BP
  • Co-head EMEA Energy and UK – Goldman Sachs Merchant Banking
  • Director – First Reserve
  • Director – Advent

Stanley Capital has formed an Automation and AI solutions business in partnership with leading AI providers such as Math Labs and Eigen Technologies in order to create proprietary products both for the running of Stanley Capital and for value creation in its investments as well as portfolio companies

A Stanley Capital investment is based on deep thematic research across our three core verticals. Our Research team seeks to develop deep insights into specific subsectors helping us to fully understand the underlying market and its players better and earlier than our competition. A Vice President, an Associate and an Analyst dedicated to research assist our deal thesis development as well as our early identification of potential targets. Our subsector research papers define, assess and segment each market and their respective competitive landscapes.

image description

Healthcare

Stanley Capital has formed an Automation and AI solutions business in partnership with leading AI providers such as Math Labs and Eigen Technologies in order to create proprietary products both for the running of Stanley Capital and for value creation in its investments as well as portfolio companies

A Stanley Capital investment is based on deep thematic research across our three core verticals. Our Research team seeks to develop deep insights into specific subsectors helping us to fully understand the underlying market and its players better and earlier than our competition. A Vice President, an Associate and an Analyst dedicated to research assist our deal thesis development as well as our early identification of potential targets. Our subsector research papers define, assess and segment each market and their respective competitive landscapes.

image description

Prodipto Ghosh

AI / Automation
Career Highlights:
  • Prodipto led the analysis of optimal mathematical solutions for world’s fastest supercomputers and several pioneering enterprise solutions based on/inspired by Quantum Computing / Mathematics as the Lead AI Scientist at McKinsey
  • He led mathematical assessments of several target AI / Machine-learning firms for investments worth $0.25b+ including a strategic initiative at a top 3 UK bank
  • Conceptualized and built range of nlp-based engines for financial services – incl. concepts discovery, impact & graphs-ts modelling, plus a customer ‘latent-aspects’ engine (for granular breakdown of equity-sentiment)
  • Prodipto holds a B.Tech from the Indian Institute of Technology Kanpur, an MBA with a focus on quantitative methods from IIM Bangalore and a Masters in Quantitative Finance from the London Business School
Background:
  • Chief Scientist – Math Labs
  • Formerly Lead AI Scientist – McKinsey
image description

Erez Raanan

AI / Automation
Technology
Career Highlights:
  • Erez led McKinsey Analytics Ventures globally and led 15+ Data and Analytics acquisitions in the last 3 years including QuantumBlack (leading AI company with 300+ FTEs), Analytics Operations Engineering (“AOE”), ISparkBeyond (AI platform)
  • Erez has an MBA from Harvard Business School, BSc in Electrical and Computer Engineering (1st in class, summa cum laude), and Data Science certification from Carnegie Mellon University
Background:
  • CEO – AIOLA
  • Director – Math Labs
  • Formerly Head of AI – McKinsey

Stanley Capital has formed an Automation and AI solutions business in partnership with leading AI providers such as Math Labs and Eigen Technologies in order to create proprietary products both for the running of Stanley Capital and for value creation in its investments as well as portfolio companies

A Stanley Capital investment is based on deep thematic research across our three core verticals. Our Research team seeks to develop deep insights into specific subsectors helping us to fully understand the underlying market and its players better and earlier than our competition. A Vice President, an Associate and an Analyst dedicated to research assist our deal thesis development as well as our early identification of potential targets. Our subsector research papers define, assess and segment each market and their respective competitive landscapes.

image description

Greg Caswill

Healthcare Services
Technology
Career Highlights:
  • Current Chairman and founder of Envision Pharma, a Med Affairs services and software company
  • Global healthcare leader with a strong entrepreneurial and investment track record and successful exits
  • Previously founder and managing director of a specialist medical communications Agency
  • Greg is a chartered accountant by background
Background:
  • Chairman Envision Pharma
image description

Sharon Curran

Healthcare
Career Highlights:
  • Highly experienced big pharma executive leading high impact global marketing, commercialization + growth strategies through strategic guidance, leadership and decision-making scrutiny for world class pharmaceutical corporations
  • Prior senior leadership experience at Abbott Pharmaceuticals and Eli Lilly
  • Sharon holds a BSc Biotechnology from Dublin City University and a MSc Business Administration from Trinity College Dublin
Background:
  • Board Member of Noden Pharma
  • Non-executive Director of Clinigen Group plc and Circassia Group plc
  • Former Senior Vice President AbbVie
image description

Xavier Flinois

Technology
Healthcare Services
Career Highlights:
  • Former President of PAREXEL Informatics and Member of the Executive Leadership ream of PAREXEL, a CEO and Director of blue-chip publicly listed tech and services businesses (Schlumberger, Atos, PAREXEL). Xavier was recognized as one of the 2016 ComputerWorld Premier 100 Technology Leaders and of the 2018 PharmaVoice 100 most inspiring people in the Life Science
  • Xavier is an Ecole Polytechnique graduate
Background:
  • Ex CEO of PI
image description

Brian Hepburn

Healthcare Services
Technology
Career Highlights:
  • Co founded Envision Pharma in 2001 and previously a director at PPSI
  • 30 years of experience from Pharma and associated service organizations in roles encompassing clinical research, marketing, medical communications and publications
  • Brian holds a BSc in Microbiology from The University of Glasgow
Background:
  • CEO Envision Pharma
image description

Royston Hoggarth

Technology
Career Highlights:
  • Royston held senior executive roles at leading technology companies such as BT, ANT plc, Cable & Wireless plc, IBM
  • Supplemented by non-executive roles across multiple industries
  • Technology and data/analytics focused product and services businesses across industries
Background:
  • Senior leader with multiple executive and non-executive roles in technology companies
image description

Alexander Mironov

Healthcare
Career Highlights:
  • Alexander Mironov has more than 20 years of leadership in corporate and business development, mergers and acquisitions, licensing and operations experience
  • Led transactions in the pharmaceutical space totaling over $5 billion in value including M&A, licensing, and equity and debt financings
  • Held senior positions with public and private equity funded growth oriented companies such as Alvogen, EKR Therapeutics, Esprit Pharma and Valera Pharmaceuticals, starting his career at Pfizer
  • Alexander holds a BS in Biochemistry from Rutgers University
Background:
  • Board Member of Noden Pharma
  • President of LifeMD’s
  • Former Chief Business Officer for Covis Pharma
image description

Rob Piconi

Resource Efficiency
Healthcare Services
Career Highlights:
  • Rob is a serial entrepreneur and investor with a wealth of diverse experience through his prior executive leadership roles at Fortune 100 public companies in the healthcare and technology space as well as the resource efficiency space
  • Current CEO of Energy Vault which develops sustainable energy storage solutions that are transforming the world’s approach to utility-scale energy storage for grid resiliency
  • Former CEO and Founder of a leading Healthcare Technology Management business with >$100m EBITDA, who has a strong track of value creation and successful exits
  • Current Chairman of a leading diagnostic imaging manufacturer
Background:
  • CEO Energy Vault
  • Ex CEO of Althea Group
image description

Björn von Siemens

Healthcare
Technology
Career Highlights:
  • Entrepreneur & investor with a focus on ventures that improve human health through data-driven solutions
  • Founder of caresyntax, a leading developer of surgical intelligence technologies working to make mission-critical settings smarter and safer, with over 3 million surgeries
  • Managing Director of surgical.ai, a private SPAC healthcare investment company with over $200m assets under management focused on surgical technology and data platforms serving hospitals, insurance, robotics, and government stakeholders
  • Member of the CREO syndicate, a public charity founded by wealth owners and family offices with a mission to address some of the most pressing environmental challenges of our time
  • Björn is a Graduate of the London School of Economics; postgraduate research as a PhD candidate at the University of St. Gallen and Harvard University
Background:
  • Founder and CBO of caresyntax Corp
  • Managing Director of surgical.ai
image description

Gary Spellins

Technology
Healthcare Services
Career Highlights:
  • During 18 years leading Private Equity backed businesses he has been Chair at Inflexion LLP backed Reed & Mackay, a global corporate travel management and solutions company servicing the financial and professional services market as well Inflexion LLP backed Scott Dunn, an international luxury tour operator specialising in premium tailor-made holidays
  • Gary was also Chair at The Parts Alliance, an Hg Capital investment in the automotive sector leading the buy and build strategy that built the business to the number 2 player in the UK. Parts Alliance was successfully sold in 2017
Background:
  • CEO Independent Clinical Services, Europe’s leading healthcare staffing and professional services company
image description

Dr Donald Weir

Resource Efficiency
Technology
Career Highlights:
  • Donald trained as an electrical and control engineer and has more than 20 years of experience in the power distribution industry, first with Landis & Gyr then with Siemens where he was CEO of the global Power Transmission & Distribution Service business unit
  • He was the CEO of E.ON Technologies with responsibility for both innovation, design and technical service to E.ON’s assets
  • Donald has an MA from Cambridge, an MSc from Imperial College London and DPhil from Oxford
Background:
  • Ex CEO Thyssen Krupp Industrial Services
  • Ex CEO Siemens Compression and Solutions